CC
CC icon

Covalis Capital’s Chemours CC Stock Holding History

Covalis Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-518,840
Closed -$8.77M – 60
2024
Q4 		$8.77M Buy
+518,840
New +$10.1M 1.28% 27
2024
Q3 		– Sell
-205,502
Closed -$4.64M – 59
2024
Q2 		$4.64M Buy
205,502
+151,330
+279% +$3.96M 0.63% 39
2024
Q1 		$1.42M Buy
+54,172
New +$1.54M 0.18% 49
2023
Q2 		– Sell
-89,836
Closed -$2.69M – 43
2023
Q1 		$2.69M Buy
+89,836
New +$2.96M 0.75% 27
2022
Q4 		– Sell
-201,823
Closed -$4.97M – 51
2022
Q3 		$4.97M Buy
+201,823
New +$6.66M 1.14% 24
2022
Q2 		– Sell
-148,118
Closed -$4.66M – 66
2022
Q1 		$4.66M Buy
+148,118
New +$4.63M 1.27% 29
2021
Q4 		– Sell
-210,162
Closed -$6.11M – 88
2021
Q3 		$6.11M Buy
+210,162
New +$6.8M 1.41% 23
2021
Q2 		– Sell
-211,635
Closed -$5.91M – 130
2021
Q1 		$5.91M Buy
+211,635
New +$5.63M 1.21% 25

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Covalis Capital's CC Position: Q1 2025 in Review

Covalis Capital sold out of Chemours (CC) in Q1 2025, closing a stake of 518,840 shares — an estimated $8.77M sold.

Covalis Capital first reported a position in CC in Q1 2021 and held it in 8 quarters. The position peaked at $8.77M in Q4 2024. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

  • Covalis Capital reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
  • Covalis Capital sold 518,840 Chemours shares in Q1 2025, an estimated $8.77M.
  • Covalis Capital first reported a position in Chemours in Q1 2021 and held it in 8 quarters.
  • Covalis Capital's Chemours position peaked at $8.77M in Q4 2024.
  • 419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on Covalis Capital's 13F filing for Q1 2025, filed 15 May 2025.